Candel Therapeutics, Inc. ( CADL ) on Wednesday revealed final survival data from a phase 2a trial of CAN-2409 in patients with stage III/IV NSCLC, inadequately responding to Immune Checkpoint Inhibitor (ICI) treatment. The median overall survival (mOS) was 24.5 months in 46 evaluable patients receiving 2 courses of CAN-2409 and 21.5 months in evaluable patients from cohort 2 (n=41)...

Atmus Filtration Technologies Inc. ( ATMU ) has strong growth potential, driven by its ability to expand in core and adjacent markets, according to JPMorgan analyst Tami Zakaria. On Thursday, Zakaria raised the stock’s price forecast from $44 to $46, and maintained an Overweight rating. Zakaria writes that with steady cash flows and a strong balance sheet, the company is...

03:36 PM EDT, 03/27/2025 (MT Newswires) -- Coca-Cola (KO) and its bottling partners plan to invest over $1.4 billion in Argentina over the next four years, multiple news outlets reported Thursday, citing company CFO John Murphy. The company plans to strengthen operations and prepare for future demand, Murphy reportedly said after meeting with Argentina's President Javier Milei. Coca-Cola will partner...

Soleno Therapeutics, Inc. ( SLNO ) shares are trading higher Thursday after the company secured FDA approval for its first commercial drug, Vykat XR (diazoxide choline) extended-release tablets. What To Know: The drug is approved to treat hyperphagia in adults and children aged 4 years and older with Prader-Willi syndrome (PWS), a rare genetic disorder that causes insatiable hunger and...